Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4269)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 25, 2024 (publication date) through Mar 5, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism. World J Nephrol 2024; 13(2): 95410 [PMID: 38983761 DOI: 10.5527/wjn.v13.i2.95410] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism. World J Nephrol 2024; 13(2): 95410 [PMID: 38983761 DOI: 10.5527/wjn.v13.i2.95410] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v13/i2/95410.htm |
| Number | Citing Articles |
| 1 |
Tingting Yuan, Hong Wang, Ting Kang, Weihua Wu, Santao Ou. Advancements in the non-invasive diagnosis of renal fibrosis. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1646412
|
| 2 |
Rucui Yu, Ruiying Wu, Tingting Chen, Yan Zhang, Xiangqing Chen. Yiqi Yangyin Tongluo Recipe Alleviates Diabetic Kidney Disease Through AGE-RAGE Signalling Axis. Diabetes, Metabolic Syndrome and Obesity 2025; : 2041 doi: 10.2147/DMSO.S523784
|
| 3 |
Yi Wei Chen, Shan He, Yu Wang, Lian Ying Hu, Qin Kai Chen, Si Yi Liu. Mitochondrial insights: key biomarkers and potential treatments for diabetic nephropathy and sarcopenia. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1596204
|
| 4 |
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637
|
| 5 |
Lan Wang, Jinwei Wang, Wei Wu, Xue Xue, Tianmai He, Shenhui Lv, Wenjing Wu, Qingqing Sun, Quan Zhou, Siyang Zhang, Sipin Han, Yu Zhao, Xinrong Zou, Dingkun Gui, Xiaoqin Wang. Prognostic Factors of Diabetic Kidney Disease and Therapeutic Effects of Shenyuan Granules: A Real-World Prospective Cohort Study. Integrative Medicine in Nephrology and Andrology 2025; 12(4) doi: 10.1097/IMNA-D-25-00031
|
| 6 |
Zongtao Li, Yashi Wang, Die Fang, Yiman Wang, Hongzhe Han, Xueqin Zhang, Zhiqiang Chen. Effects of rutin on renal function, oxidative stress and fibrosis in animal models of diabetic nephropathy: a systematic review and meta-analysis. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1771010
|
| 7 |
Yan-ni Wang, Xin Wu, Qi-yan Shan, Qiao Yang, Xiao-yong Yu, Jian-hua Yang, Hua Miao, Gang Cao, Ying-yong Zhao. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacologica Sinica 2025; 46(11): 2975 doi: 10.1038/s41401-025-01598-4
|
| 8 |
Haojie Liu, Xiadan Xiang, Chengqian Shi, Jiaowei Guo, Ting Ran, Jinglian Lin, Futing Dong, Jie Yang, Hua Miao. Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targets. Chemico-Biological Interactions 2025; 421: 111784 doi: 10.1016/j.cbi.2025.111784
|
| 9 |
Jin Sun, Mengqing Ma, Hao Zhang, Hao Hu, Yuanyuan Liu, Wanwan Zhang, Binbin Pan, Xin Wan. A novel biomarker Ins60/ApoA for predicting diabetic kidney disease in newly diagnosed type 2 diabetes: a pilot study. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1569730
|
| 10 |
Bingxue Qi, Yang Chen, Siyang Chai, Xiaodan Lu, Li Kang. O‐linked β‐N‐acetylglucosamine (O‐GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy. Diabetic Medicine 2025; 42(2) doi: 10.1111/dme.15436
|
| 11 |
Ye Jiang, Jing Chang, You Guo, Zhe Liu, Xiaomeng Feng. TangShenWeiNing formula alleviates diabetic kidney disease by inhibiting ferroptosis via AMPK pathway in renal tubular epithelial cells. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1749994
|
| 12 |
Junming Huang, Dong Pang, Chenglong Fan, Guanglin Yang, Jinji Chen, Shaohua Chen. Integrative transcriptomic and machine learning analyses identify HDAC9 as a key regulator of mitochondrial dysfunction and senescence-associated inflammation in diabetic nephropathy. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1627173
|
| 13 |
Hua Miao, Kai-En Wang, Ping Li, Ying-Yong Zhao. Rhubarb: Traditional Uses, Phytochemistry, Multiomics-Based Novel Pharmacological and Toxicological Mechanisms. Drug Design, Development and Therapy 2025; : 9457 doi: 10.2147/DDDT.S557114
|
| 14 |
Jianwei Ma, Qin Su, Hanlu Wang, Jiayan Xu, Chenyi Yuan, Guicai Fan, Jiapei Ying, Xueyan Bian. Efficacy and Safety of Finerenone Combined with Dapagliflozin in the Treatment of Non-Diabetic Chronic Kidney Disease: A Single-Center Retrospective Study. Drug Design, Development and Therapy 2026; : 1 doi: 10.2147/DDDT.S564942
|